Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Abatacept may help some people with alopecia areata regrow hair.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Mogamulizumab can cause hair loss and skin rashes.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Tofacitinib helped regrow hair in a woman with alopecia areata.